A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

Abroad (travel likely)RecruitingPHASE3

Conditions

Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Research Site, Largo, Florida, United States

  • Research Site, Fort Wayne, Indiana, United States

  • Research Site, Omaha, Nebraska, United States

  • Research Site, New York, New York, United States

  • Research Site, Houston, Texas, United States

  • Research Site, Puyallup, Washington, United States

  • Research Site, Beijing, China

  • Research Site, Changsha, China

  • Research Site, Guangzhou, China

  • Research Site, Linyi, China

  • Research Site, Shandong, China

  • Research Site, Wuhan, China

  • Research Site, Zhengzhou, China

  • Research Site, Clermont-Ferrand, France

  • Research Site, La Roche-sur-Yon, France

  • Research Site, Montpellier, France

  • Research Site, Paris, France

  • Research Site, Pierre-Bénite, France

  • Research Site, Aviano, Italy

  • Research Site, Florence, Italy

  • Research Site, Meldola, Italy

  • Research Site, Milan, Italy

  • Research Site, Naples, Italy

  • Research Site, Roma, Italy

  • Research Site, Bukgu, South Korea

  • Research Site, Goyang-si, South Korea

  • Research Site, Seoul, South Korea

  • Research Site, Seoul, South Korea

  • Research Site, Seoul, South Korea

  • Research Site, Seoul, South Korea

  • Research Site, Seoul, South Korea

  • Research Site, Seoul, South Korea

  • Research Site, Seoul, South Korea

  • Research Site, A Coruña, Spain

  • Research Site, Barcelona, Spain

  • Research Site, Granada, Spain

  • Research Site, Madrid, Spain

  • Research Site, Madrid, Spain

  • Research Site, Seville, Spain

  • Research Site, Valencia, Spain